Starling Oncology (STLN)
Nasdaq • STLN • US68236X1000
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 22, 2026, ORTEX estimated 7.6% of free float sold short, 5.9 days to cover, cost to borrow 0.43%. Sign up for live short interest data.
Market Cap
369m USD | # 6452 in US
Volume
1.65m shares | 10.61m USD
Shares Outstanding
101.92m
Free Float Shares
87.22% | 88.89m
